These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23582276)

  • 1. Analysis of the molecular interactions of the potent analgesic S1RA with the σ1 receptor.
    Laurini E; Da Col V; Wünsch B; Pricl S
    Bioorg Med Chem Lett; 2013 May; 23(10):2868-71. PubMed ID: 23582276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release in the spinal cord in rats.
    Vidal-Torres A; Fernández-Pastor B; Carceller A; Vela JM; Merlos M; Zamanillo D
    J Neurochem; 2014 May; 129(3):484-94. PubMed ID: 24384038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862).
    Díaz JL; Cuberes R; Berrocal J; Contijoch M; Christmann U; Fernández A; Port A; Holenz J; Buschmann H; Laggner C; Serafini MT; Burgueño J; Zamanillo D; Merlos M; Vela JM; Almansa C
    J Med Chem; 2012 Oct; 55(19):8211-24. PubMed ID: 22784008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the σ1 receptor and its ligand binding site.
    Brune S; Pricl S; Wünsch B
    J Med Chem; 2013 Dec; 56(24):9809-19. PubMed ID: 23964901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.
    Romero L; Zamanillo D; Nadal X; Sánchez-Arroyos R; Rivera-Arconada I; Dordal A; Montero A; Muro A; Bura A; Segalés C; Laloya M; Hernández E; Portillo-Salido E; Escriche M; Codony X; Encina G; Burgueño J; Merlos M; Baeyens JM; Giraldo J; López-García JA; Maldonado R; Plata-Salamán CR; Vela JM
    Br J Pharmacol; 2012 Aug; 166(8):2289-306. PubMed ID: 22404321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9.
    Sánchez-Blázquez P; Pozo-Rodrigálvarez A; Merlos M; Garzón J
    Mol Neurobiol; 2018 Jun; 55(6):4940-4951. PubMed ID: 28779350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary bladder sigma-1 receptors: A new target for cystitis treatment.
    González-Cano R; Artacho-Cordón A; Romero L; Tejada MA; Nieto FR; Merlos M; Cañizares FJ; Cendán CM; Fernández-Segura E; Baeyens JM
    Pharmacol Res; 2020 May; 155():104724. PubMed ID: 32105755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal Chemistry of σ
    Weber F; Wünsch B
    Handb Exp Pharmacol; 2017; 244():51-79. PubMed ID: 28620761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
    Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
    J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The σ(1) receptor antagonist S1RA is a promising candidate for the treatment of neurogenic pain.
    Wünsch B
    J Med Chem; 2012 Oct; 55(19):8209-10. PubMed ID: 22951043
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of 2-(3,4-dichlorophenoxy)-N-(2-morpholin-4-ylethyl)acetamide: A selective σ1 receptor ligand with antinociceptive effect.
    Navarrete-Vázquez G; Austrich-Olivares A; Godínez-Chaparro B; Hidalgo-Figueroa S; Estrada-Soto S; Hernández-Núñez E; Torres-Gómez H; Schepmann D; Wünsch B
    Biomed Pharmacother; 2016 Apr; 79():284-93. PubMed ID: 27044839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity sigma-1 (σ
    Niso M; Mosier PD; Marottoli R; Ferorelli S; Cassano G; Gasparre G; Leopoldo M; Berardi F; Abate C
    Future Med Chem; 2019 Oct; 11(19):2547-2562. PubMed ID: 31633399
    [No Abstract]   [Full Text] [Related]  

  • 13. Reevaluation of fenpropimorph as a σ receptor ligand: Structure-affinity relationship studies at human σ
    Sguazzini E; Schmidt HR; Iyer KA; Kruse AC; Dukat M
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2912-2919. PubMed ID: 28495085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma receptor ligands protect human retinal cells against oxidative stress.
    Bucolo C; Drago F; Lin LR; Reddy VN
    Neuroreport; 2006 Feb; 17(3):287-91. PubMed ID: 16462599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure.
    Schläger T; Schepmann D; Würthwein EU; Wünsch B
    Bioorg Med Chem; 2008 Mar; 16(6):2992-3001. PubMed ID: 18221879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship study of a new series of selective σ(1) receptor ligands for the treatment of pain: 4-aminotriazoles.
    Díaz JL; Christmann U; Fernández A; Torrens A; Port A; Pascual R; Álvarez I; Burgueño J; Monroy X; Montero A; Balada A; Vela JM; Almansa C
    J Med Chem; 2015 Mar; 58(5):2441-51. PubMed ID: 25658964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability.
    Rossi D; Marra A; Picconi P; Serra M; Catenacci L; Sorrenti M; Laurini E; Fermeglia M; Pricl S; Brambilla S; Almirante N; Peviani M; Curti D; Collina S
    Bioorg Med Chem; 2013 May; 21(9):2577-86. PubMed ID: 23498917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.
    Motawe ZY; Abdelmaboud SS; Cuevas J; Breslin JW
    Int J Biochem Cell Biol; 2020 Sep; 126():105803. PubMed ID: 32668330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties.
    Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Pittalà V; Pappalardo MS; Cacciaguerra S; Spampinato S
    J Med Chem; 1998 May; 41(10):1574-80. PubMed ID: 9572883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.
    Dichiara M; Artacho-Cordón A; Turnaturi R; Santos-Caballero M; González-Cano R; Pasquinucci L; Barbaraci C; Rodríguez-Gómez I; Gómez-Guzmán M; Marrazzo A; Cobos EJ; Amata E
    Eur J Med Chem; 2022 Feb; 230():114091. PubMed ID: 35016113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.